Piramal Pharma Ltd (PIRM)

Currency in INR
202.50
+3.22(+1.62%)
Closed·

Piramal Pharma (PIRM) Stock Forecast & Price Target

Advanced Equity Forecast
Overall Consensus
Strong Buy
10 Buy
0 Hold
1 Sell
Data based on a poll of the past 3 months

Analysts 12-Month Price Target

Average 231.45
(+14.30% Upside)

Past 24 Months

12-Month Forecast

Analyst Ratings

Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
ICICI Securities
Buy245.00+20.99%210.00Maintain31/07/2026
Goldman Sachs
Buy200.00-1.23%225.00Maintain30/01/2026
Jefferies
Buy210.00+3.70%235.00Maintain09/01/2026
Axis Capital Limited
Buy220.00+8.64%230.00Maintain07/11/2025
Kotak
Buy310.00+53.09%325.00Maintain07/11/2025

Fair Value

Average
Downside
Uncertainty
Spread
Market Range
52 weeks
₹132
₹209
Analyst Targets
11 analysts
₹200
₹265
Fair Value
12 models

FAQ

Is Piramal Pharma (PIRM) a Buy, Sell or Hold?

The consensus rating for Piramal Pharma is "Strong Buy", based on insights from 11 analysts. 10 analysts recommend buying the stock, 1 suggest selling, and 0 recommend holding, according to PIRM share price forecasts.

What Is the Share Price Target for Piramal Pharma (PIRM) According to Analysts?

According to projections from 11 analysts, the average 12-month share price target for Piramal Pharma is 231.45 INR, with a high estimate of 265 INR and a low estimate of 200 INR.

What Is PIRM’s Potential Upside or Downside, Based on the Analysts’ Average Price Target?

Piramal Pharma has a potential Upside of +14.30%, based on analysts’ average share price forecast targets.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.